Reita, D.; Pabst, L.; Pencreach, E.; Guérin, E.; Dano, L.; Rimelen, V.; Voegeli, A.-C.; Vallat, L.; Mascaux, C.; Beau-Faller, M.
Molecular Mechanism of EGFR-TKI Resistance in EGFR-Mutated Non-Small Cell Lung Cancer: Application to Biological Diagnostic and Monitoring. Cancers 2021, 13, 4926.
https://doi.org/10.3390/cancers13194926
AMA Style
Reita D, Pabst L, Pencreach E, Guérin E, Dano L, Rimelen V, Voegeli A-C, Vallat L, Mascaux C, Beau-Faller M.
Molecular Mechanism of EGFR-TKI Resistance in EGFR-Mutated Non-Small Cell Lung Cancer: Application to Biological Diagnostic and Monitoring. Cancers. 2021; 13(19):4926.
https://doi.org/10.3390/cancers13194926
Chicago/Turabian Style
Reita, Damien, Lucile Pabst, Erwan Pencreach, Eric Guérin, Laurent Dano, Valérie Rimelen, Anne-Claire Voegeli, Laurent Vallat, Céline Mascaux, and Michèle Beau-Faller.
2021. "Molecular Mechanism of EGFR-TKI Resistance in EGFR-Mutated Non-Small Cell Lung Cancer: Application to Biological Diagnostic and Monitoring" Cancers 13, no. 19: 4926.
https://doi.org/10.3390/cancers13194926
APA Style
Reita, D., Pabst, L., Pencreach, E., Guérin, E., Dano, L., Rimelen, V., Voegeli, A.-C., Vallat, L., Mascaux, C., & Beau-Faller, M.
(2021). Molecular Mechanism of EGFR-TKI Resistance in EGFR-Mutated Non-Small Cell Lung Cancer: Application to Biological Diagnostic and Monitoring. Cancers, 13(19), 4926.
https://doi.org/10.3390/cancers13194926